Page (1) of 1 - 03/20/12
FDA panel backs Glaxo drug for rare sarcoma cancer
FDA panel supports Glaxo drug for rare soft tissue tumors, though drug did not extend life
By The Associated Press
Rare Cancer Drugs-FDA, Cancer, Tumors, Medication, Diseases and conditions, Health, Diagnosis and treatment
Source:Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed..
All Rights Reserved